HTFL vs NNOX vs LNTH Stock Comparison

Heartflow, Nano-X Imaging and Lantheus Holdings Prices as of Oct 27, 2026 Peers: Industry group
HTFL Heartflow, Inc.
$57.82 +17.6% 1M +50.8% 1Y
Market cap
$5.01B
P/E
–
Revenue (TTM)
$202.91M
Div. yield
–
Diagnostic Equipment Healthcare
1 win
NNOX Nano-X Imaging Ltd.
$0.32 -50.0% 1M -92.1% 1Y
Market cap
$22.27M
P/E
–
Revenue (TTM)
$15.63M
Div. yield
–
Diagnostic Equipment Healthcare
LNTH Lantheus Holdings, Inc.
$100.15 +0.4% 1M +72.3% 1Y
Market cap
$6.54B
P/E
23.7x
Revenue (TTM)
$1.56B
Div. yield
–
Diagnostic Equipment Healthcare
8 wins

Head to Head

9 decided of 12

Lantheus Holdings leads on 8 of the 12 questions below (Lantheus Holdings 8, Heartflow 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHTFLNNOXLNTHLeader
Larger companyMarket capitalisation $5.01B $22.27M $6.54B LNTH
Cheaper on earningsLower P/E, profitable companies only -49.9x -0.2x 23.7x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 17.4x –
Faster revenue growthRevenue growth, trailing twelve months +42.5% +31.5% +2.3% HTFL
More profitableNet margin, trailing twelve months -49.4% -747.2% 17.7% LNTH
Better return on capitalReturn on invested capital — -116.9% 12.5% LNTH
Less leveragedLower net debt / EBITDA — 0.3x -0.1x LNTH
Higher dividend yieldTrailing dividend yield — — — –
Better 1-year returnPrice return, last 12 months +50.8% -92.1% +72.3% LNTH
Better 5-year returnAnnualised price return, 5 years — -57.4%/yr +34.4%/yr LNTH
Less volatileAnnualised volatility, 1 year 76.7% 105.8% 32.3% LNTH
Higher overall scoreMean of the five percentile scores vs peers 57/100 36/100 80/100 LNTH

Percentile Scorecard

HTFLNNOXLNTH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHTFLNNOXLNTH
Valuation 9 #207 of 227 54 #105 of 227 80 #46 of 227
Growth 78 #49 of 219 10 #198 of 219 63 #82 of 219
Profitability 49 #106 of 206 10 #185 of 206 94 #13 of 206
Financial Health 92 #20 of 238 71 #71 of 238 69 #74 of 238
Shareholder Returns – – 93 #11 of 134
Overall 57 36 80
  • HTFL ranked among 247 companies in Medical Devices and Diagnostics
  • NNOX ranked among 247 companies in Medical Devices and Diagnostics
  • LNTH ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHTFLNNOXLNTHSPY
1 month +17.6%-50.0%+0.4% -0.2%
3 months +125.9%-63.6%-2.4% +3.9%
6 months +89.3%-82.2%+19.9% +8.2%
Year to date +98.4%-88.6%+50.5% +12.9%
1 year +50.8%-92.1%+72.3% +12.3%
3 years —-93.6%+49.9% +87.4%
3 years, per year —-60.1%+14.4% +23.3%
5 years —-98.6%+337.5% +67.9%
5 years, per year —-57.4%+34.4% +10.9%
10 years ——+1,092.3% +261.1%
10 years, per year ——+28.1% +13.7%

Risk

MeasureHTFLNNOXLNTHSPY
Volatility, 1Y 76.7%105.8%32.3% 12.7%
Downside volatility, 1Y 77.5%116.3%27.5% 12.7%
Beta vs S&P 500, 1Y 1.901.360.59 1.00
Return / volatility, 1Y 0.66-0.872.24 0.97
Max drawdown, 5Y -48.7%-98.8%-59.5% -25.4%
From 52-week high 0.0%-93.0%-9.7% -1.2%
52-week high $57.82$4.55$110.94 $779.14
52-week low $20.49$0.32$50.69 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHTFLNNOXLNTH
P/E now vs peer median -49.9xmedian 29.6x -0.2xmedian 29.6x 23.7xmedian 29.6x
P/S now vs peer median 24.7xmedian 2.9x 1.4xmedian 2.9x 4.2xmedian 2.9x
EV/EBITDA now vs peer median —median 17.4x 0.1xmedian 17.4x 16.5xmedian 17.4x
P/FCF now vs peer median —median 22.3x -0.4xmedian 22.3x 16.9xmedian 22.3x
P/B now vs peer median 17.9xmedian 2.3x 0.3xmedian 2.3x 5.0xmedian 2.3x
PEG now vs peer median —median 1.04 -0.08median 1.04 0.22median 1.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHTFLNNOXLNTH
Revenue $202.91M $15.63M $1.56B
Gross profit $160.45M -$52.76M $936.02M
Operating income -$64.46M -$119.69M $302.34M
Net income -$100.19M -$116.81M $275.31M
Free cash flow – -$52.09M $387.83M
R&D $77.26M $18.93M $173.09M
EPS (diluted) $-1.16 $-1.80 $4.08
Cash & equivalents $34.36M $31.02M $593.30M
Total debt – $12.50M $571.05M
Shares (diluted) 86.40M 64.79M 67.52M
Enterprise value $4.77B -$157.41M $4.70B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHTFLNNOXLNTH
P/E -49.9x -0.2x 23.7x
P/FCF – -0.4x 16.9x
P/Operating cash flow – -0.5x 15.8x
P/S 24.7x 1.4x 4.2x
P/B 17.9x 0.3x 5.0x
P/Tangible book 17.9x 0.4x 10.5x
EV/EBITDA – 0.1x 16.5x
EV/EBIT -74.0x 0.0x 21.5x
EV/Revenue 23.5x -0.4x 4.2x
EV/FCF – 0.1x 16.8x
EV/Operating cash flow – 0.1x 15.8x
PEG (3Y EPS CAGR) – -0.08 0.22

Growth

14 metrics
MetricHTFLNNOXLNTH
Revenue growth (1Y) 42.5% 31.5% 2.3%
Revenue CAGR (3Y) – 17.7% 11.4%
Gross profit growth (1Y) 48.8% -340.0% -3.4%
Gross profit CAGR (3Y) – -101.8% 16.3%
Operating income growth (1Y) -9.5% -107.4% -30.9%
Operating income CAGR (3Y) – -5.0% 118.8%
Net income growth (1Y) -18.3% -109.9% 1.6%
Net income CAGR (3Y) – -4.9% 102.1%
EPS growth (1Y) 91.4% -90.0% 5.8%
EPS CAGR (3Y) – 2.3% 105.5%
Operating cash flow growth (1Y) – -21.9% -21.7%
Operating cash flow CAGR (3Y) – -2.7% 14.5%
Free cash flow growth (1Y) – -19.4% -10.1%
Free cash flow CAGR (3Y) – 1.3% 103.0%

Profitability

14 metrics
MetricHTFLNNOXLNTH
Gross margin 79.1% -337.5% 60.1%
EBITDA margin – -692.4% 25.4%
Operating margin -31.8% -765.6% 19.4%
Pretax margin -49.4% -758.5% 23.3%
Net margin -49.4% -747.2% 17.7%
FCF margin – -333.2% 24.9%
Operating cash flow margin – -298.7% 26.5%
Return on equity -34.5% -117.5% 21.8%
Return on assets -28.5% -98.6% 11.6%
Return on invested capital – -116.9% 12.5%
Return on capital employed -20.9% -114.2% 14.8%
Asset turnover 0.6x 0.1x 0.7x
Cash conversion (OCF / net income) – 0.4x 1.5x
Stock comp / revenue 9.6% 34.9% 5.0%

Financial Health

11 metrics
MetricHTFLNNOXLNTH
Debt / assets – 3.3% 23.6%
Debt / equity – 0.0x 0.4x
Net debt / EBITDA – 0.3x -0.1x
Debt / FCF – -0.1x 1.5x
Liabilities / assets 18.8% 20.5% 45.7%
Equity / assets 81.2% 79.5% 54.3%
Interest coverage – – 15.3x
Current ratio 5.1x 2.8x 3.1x
Quick ratio 6.6x 2.4x 2.8x
Cash ratio 5.6x 2.3x 1.8x
Altman Z-score 42.47 -11.07 5.46

Shareholder Returns

7 metrics
MetricHTFLNNOXLNTH
Dividend yield – – –
Net buyback yield – – 2.9%
Shareholder yield – – 2.9%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHTFLNNOXLNTH
Forward P/E – – 17.4xFY2026
EPS, next fiscal year $-0.43FY2026 $-1.31FY2026 $5.76FY2026
EPS growth, next FY – – -5.3%FY2026
EPS growth, the year after – – +4.2%
Revenue, next fiscal year $261.38MFY2026 $18.64MFY2026 $1.57BFY2026
Revenue growth, next FY +48.5%FY2026 +43.2%FY2026 +1.8%FY2026
Revenue growth, the year after +20.6% +59.6% +12.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHTFLNNOXLNTH
Held by institutions 100.0% 14.9% 100.0%
Institutions holding 192 102 465
Change in shares held, QoQ +133.0% -46.0% +3.4%
Institutions buying 140 55 248
Institutions selling 38 28 142
Buyers to sellers 3.68 1.96 1.75

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HTFLNNOXLNTH
HTFL 1.00 0.19 0.14
NNOX 0.19 1.00 0.05
LNTH 0.14 0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HTFL, NNOX and LNTH?

Lantheus Holdings (LNTH) is the largest by market capitalisation: Heartflow (HTFL) $5.01B, Nano-X Imaging (NNOX) $22.27M, Lantheus Holdings (LNTH) $6.54B.

Which company is growing faster?

Heartflow (HTFL) grew revenue fastest over the trailing twelve months: Heartflow (HTFL) +42.5%, Nano-X Imaging (NNOX) +31.5%, Lantheus Holdings (LNTH) +2.3%.

Which company is more profitable?

Lantheus Holdings (LNTH) has the highest net margin (Heartflow (HTFL) -49.4%, Nano-X Imaging (NNOX) -747.2%, Lantheus Holdings (LNTH) 17.7%). On return on invested capital, Lantheus Holdings (LNTH) leads (Nano-X Imaging (NNOX) -116.9%, Lantheus Holdings (LNTH) 12.5%).

Which stock has performed better?

Over the past year Lantheus Holdings (LNTH) returned the most: Heartflow (HTFL) +50.8%, Nano-X Imaging (NNOX) -92.1%, Lantheus Holdings (LNTH) +72.3%. Over five years, Lantheus Holdings (LNTH) compounded fastest (Nano-X Imaging (NNOX) -57.4%/yr, Lantheus Holdings (LNTH) +34.4%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Lantheus Holdings (LNTH) has been the steadiest (Heartflow (HTFL) 76.7%, Nano-X Imaging (NNOX) 105.8%, Lantheus Holdings (LNTH) 32.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, HTFL, NNOX and LNTH?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lantheus Holdings (LNTH) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.